Gastroenterologie-Leitlinien

35 aktuelle Gastroenterologie-Leitlinien von nationalen Behörden, europäischen Fachgesellschaften und HTA-Institutionen, über 11 Quellgruppen. eUvidence verankert Gastroenterologie-Antworten an diesen Leitlinien; jeder Eintrag verlinkt auf die eigene Seite der herausgebenden Institution.

Europäische Fachgesellschaften· 8

• EASL Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection

  EASL · European Association for the Study of the Liver · 2025

• EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  EASL · European Association for the Study of the Liver · 2024

• Diagnosis and Management of Barrett Esophagus: ESGE Guideline

  ESGE · European Society of Gastrointestinal Endoscopy · 2023

• Endoscopic Diagnosis and Management of Esophagogastric Variceal Hemorrhage: ESGE Guideline

  ESGE · European Society of Gastrointestinal Endoscopy · 2022

• Management of Helicobacter pylori Infection: the Maastricht VI/Florence Consensus Report

  EHMSG · European Helicobacter and Microbiota Study Group · 2022 · consensus statement

• Endoscopic Diagnosis and Management of Nonvariceal Upper Gastrointestinal Hemorrhage: ESGE Guideline - Update 2021

  ESGE · European Society of Gastrointestinal Endoscopy · 2021

• Post-Polypectomy Colonoscopy Surveillance: ESGE Guideline - Update 2020

  ESGE · European Society of Gastrointestinal Endoscopy · 2020

• EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis

  EASL · European Association for the Study of the Liver · 2018

Österreich· 2

• Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease (MASLD)

  OEGGH · Osterreichische Gesellschaft fuer Gastroenterologie und Hepatologie · 2025 · consensus statement

• Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)

  OEGGH · Osterreichische Gesellschaft fuer Gastroenterologie und Hepatologie · 2023 · consensus statement

Dänemark· 1

• Dyspepsia and Gastro-oesophageal Reflux Disease in Adults: Investigation and Treatment

  DSAM · Dansk Selskab for Almen Medicin · 2021

Finnland· 2

• Non-Alcoholic Fatty Liver Disease (NAFLD)

  Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Association for General Practice · 2020

• Coeliac Disease

  Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Society of Gastroenterology · 2018

Frankreich· 4

• Management of Persons Infected with Hepatitis C Virus

  HAS · Haute Autorite de Sante · 2024 · recommendation

• Management of Persons Infected with Hepatitis B Virus

  HAS · Haute Autorite de Sante · 2023 · recommendation

• AFEF-SFA Recommendations on the Management of Alcohol-Related Liver Disease

  AFEF · Association Francaise pour l'Etude du Foie · 2021 · recommendation

• Long-Term Illness Guide ALD No. 24: Crohn's Disease

  HAS · Haute Autorite de Sante · 2019

Deutschland· 6

• Updated S3 Guideline: Ulcerative Colitis (Version 7.0)

  DGVS · Deutsche Gesellschaft fuer Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten · 2025

• Updated S3 Guideline: Diagnosis and Treatment of Crohn's Disease (Living Guideline)

  DGVS · Deutsche Gesellschaft fuer Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten · 2024

• Updated S2k Guideline: Helicobacter pylori and Gastroduodenal Ulcer Disease

  DGVS · Deutsche Gesellschaft fuer Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten · 2023

• Updated S2k Guideline: Coeliac Disease

  DGVS · Deutsche Gesellschaft fuer Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten · 2022

• Updated S2k Guideline: Non-Alcoholic Fatty Liver Disease

  DGVS · Deutsche Gesellschaft fuer Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten · 2022

• S3 Guideline: Diverticular Disease / Diverticulitis

  DGVS · Deutsche Gesellschaft fuer Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten · 2022

Italien· 1

• Multidisciplinary Management of the Patient with Hepatocellular Carcinoma

  AISF-AIOM · Associazione Italiana per lo Studio del Fegato / Associazione Italiana di Oncologia Medica · 2022

Niederlande· 4

• Medical Treatment of Crohn's Disease (Inflammatory Bowel Disease in Adults)

  FMS · Federatie Medisch Specialisten · 2022

• Treatment of Acute Biliary Pancreatitis (Gallstone Disease)

  FMS · Federatie Medisch Specialisten · 2022

• Diagnosis of Cholecystolithiasis (Gallstone Disease)

  FMS · Federatie Medisch Specialisten · 2022

• Diagnosis of Coeliac Disease and Gluten-Related Disorders

  FMS · Federatie Medisch Specialisten · 2021

Polen· 1

• Guidelines of the Polish Society of Gastroenterology and the National Consultant on the Management of Patients with Ulcerative Colitis

  PTG-E · Polskie Towarzystwo Gastroenterologii · 2023

Spanien· 1

• GETECCU Clinical Guideline for the Treatment of Ulcerative Colitis (GRADE methodology)

  GETECCU · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa · 2013

Vereinigtes Königreich· 5

• Crohn's Disease: Management

  NICE · National Institute for Health and Care Excellence · 2019

• Ulcerative Colitis: Management

  NICE · National Institute for Health and Care Excellence · 2019

• British Society of Gastroenterology Consensus Guidelines on the Management of Inflammatory Bowel Disease in Adults

  BSG · British Society of Gastroenterology · 2019

• Cirrhosis in Over 16s: Assessment and Management

  NICE · National Institute for Health and Care Excellence · 2016

• Gallstone Disease: Diagnosis and Management

  NICE · National Institute for Health and Care Excellence · 2014